Anti-human Integrin α5β1 Recombinant Antibody (3C5) (TAB-720LC) (CAT#: TAB-720LC)
Recombinant monoclonal antibody 3C5 is a human monoclonal antibody that specifically binds to human integrin α5β1 and can be potentially used in the treatment of colon cancer and pancreatic cancer.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 A bar chart showing the effect of inhibitory α5β1 antibodies on the attachment of endothelial cells to fibronectin, in the presence of 10 μL/mL L230.
Antibody treatments are indicated on the X-axis, and compared to a no treatment control. IgG1 control, 3C5 and 5B11 were used at 10 μg/ml and 25 μg/ml as indicated. The mean cell adhesion as measured by cell count is indicated on the Y-axis, together with the standard deviation of the mean (error bars).
Figure 2 A bar chart showing the effect of inhibitory α5β1 antibodies on endothelial cell tube formation in an endothelial tube formation co-culture assay.
Antibodies are indicated on the X-axis and concentrations from left to right in each group of bars are 5 μg/mL, 1 μg/mL, 0.2 μg/mL and 0.04 μg/mL. The degree of tube formation in terms of length (mm) and bifurcations is shown on the Y-axis. The values represented are the mean +/-the standard deviation. Vessel length (mm) is represented in black bars and bifurcations in grey bars.
Figure 3 A bar chart showing the effect of inhibitory α5β1 antibodies on angiogenesis in vivo.
Treatments are represented on the X-axis: Control vehicle twice weekly; 3C5 20 mg/kg twice weekly (diagonal stripped bars); 3C5 10 mg/kg twice weekly (checked bars); The Y axis shows mean vessel density +/-the standard error.
Specifications
- Immunogen
- Human full-length α5βl
- Host Species
- Human
- Type
- Human antibody
- Specificity
- Human
- Clone
- 3C5
- Applications
- ELISA, FC, Inhib
- Related Disease
- Colon cancer and pancreatic cancer
Applications
- Application Notes
- This antibody has been tested for use in Inhibition.
Target
- Alternative Names
- Integrin α5β1; GPV/IIIa; GPV/IIa
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone 3C5"
See other products for "Integrin α5β1"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-443CL | Human Anti-Integrin α5β1 Recombinant Antibody (TAB-443CL) | ELISA | Human IgG |
TAB-719LC | Anti-human Integrin α5β1 Recombinant Antibody (3C2.2A8) (TAB-719LC) | ELISA, FC | Human antibody |
TAB-721LC | Anti-human Integrin α5β1 Recombinant Antibody (5B11) (TAB-721LC) | ELISA, FC, Inhib | Human antibody |
TAB-722LC | Anti-human Integrin α5β1 Recombinant Antibody (MOR04055) (TAB-722LC) | ELISA, FC, Block, Apop, FuncS | Human antibody |
TAB-723LC | Anti-human Integrin α5β1 Recombinant Antibody (MOR04624) (TAB-723LC) | ELISA, FC, Block, Apop | Human antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-720LC. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Application: WB, ELISA
Application: Neut, ELISA, FuncS
Application: FC, IHC-Fr, IP, ELISA, Block
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, WB
Application: ELISA, Activ, Block
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.